Challenges of local pharmaceutical manufacturer's that hinder adequate production of pharmaceutical medicine in Tanzania. (Record no. 23195)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03516nam a22003257a 4500 |
| 001 - CONTROL NUMBER | |
| control field | CUHAS/BP/3000325/T/16 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | CUHAS/BP/3000325/T/16 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305194015.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 231129b |||||||| |||| 00| 0 eng d |
| 028 ## - PUBLISHER OR DISTRIBUTOR NUMBER | |
| Source | Wurzburg Road 35, BMC Premises, Post Code: 33102: |
| Source | P. O. Box 1464, Mwanza – Tanzania: |
| Source | Phone: +255 28 298 3384: |
| Source | Fax: +255 28 298 3386: |
| Source | Email: vc@bugando.ac.tz: |
| Source | www.bugando.ac.tz |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | CUHAS/BP/3000325/T/16 |
| 040 ## - CATALOGING SOURCE | |
| Language of cataloging | English |
| Transcribing agency | DDC |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| Language code of text/sound track or separate title | Kiswahili |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Herbeth Chogga |
| Dates associated with a name | CUHAS/BP/3000325/T/16 |
| 245 ## - TITLE STATEMENT | |
| Title | Challenges of local pharmaceutical manufacturer's that hinder adequate production of pharmaceutical medicine in Tanzania. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mwanza, Tanzania: |
| Name of publisher, distributor, etc. | Catholic University of Health and Allied Sciences [CUHAS – Bugando] : |
| Date of publication, distribution, etc. | ©2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | viii; 28 Pages |
| Extent | Includes References |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Abstract: <br/><br/>Background: Pharmaceutical production began in Tanzania between 1960-1980 with four firms. The 1980s economic crisis closed down two of them, in 2018, there were more than twelve registered pharmaceutical plants in Tanzania. Among the registered plants, only five were categorized as TMDA GMP compliant pharmaceutical plants. But only seven pharmaceutical industries among the major firms are active. It is therefore imperative that challenges facing local manufacturers must be identified and addressed. <br/><br/>Problem statement: Tanzania local manufacturing of pharmaceutical inadequate to meet national demand because most of pharmaceutical manufacturing industries have collapsed. In this case 80% of medicine, 90% of medical supplies and 100% Laboratory supplies are imported whereas MSD is largest importer. <br/><br/>Methodology study area: Study was done in Dar es Salaam and Mwanza, the study included the following pharmaceutical industries; Shely’s Pharmaceutical Ltd, Mansoor Daya Chemicals Ltd, Zenufa Laboratory Ltd and Keko Pharmaceutical Ltd, from Mwanza; Prince Pharmaceutical Ltd. <br/><br/>Study Design: Cross-sectional study with qualitative inquiry<br/><br/>Results: The challenges identified by Tanzania manufactures were comparable to be findings of studies conducted in other developing countries. The biggest challenges was lack of accessory industries and from this led to other challenges like unfair competition with imported products, price, and unavailability of raw materials was among the challenges that manufacturers perceived as hindering increased capacity. In addition, in contrast to other studies requirement to adhere to Good Manufacturing Practice (GMP) regulations was not perceived to be a challenge that hindered increased production of essential medicine but rather an obligation for them to remain competitive and all manufacturing industries are shown to comply with GMP requirements. <br/><br/>Conclusion: To attain adequate production of pharmaceutical medicines there must be collaborative effort between local manufacturers, Government and the society who are primary consumers of the pharmaceutical medicine. The government must put supportive environments for investors in production of pharmaceutical industries including linking between ministry of Education, Agriculture, Ministry of Power and Industries and Trade and pharmaceutical manufactures. <br/> |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Pharmacy |
| General subdivision | Pharmacology |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | UNDERGRADUATE DISSERTATIONS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/29/2023 | CUHAS/BP/3000325/T/1 | 11/29/2023 | 11/29/2023 | UNDERGRADUATE DISSERTATIONS |